Update on breast cancer susceptibility genes.

作者: B. L. Weber

DOI: 10.1007/978-3-642-45769-2_5

关键词: PenetranceColorectal cancerCancer researchOvarian cancerMedicineMSH2Breast cancerAutosomal dominant traitGenePopulation

摘要: Approximately 7% of breast cancer and 10% ovarian in the United States is thought to be due presence an autosomal dominant susceptibility allele. Two genes (BRCA1 BRCA2) now have been identified (Miki et al. 1994; Wooster 1995; Tavtigian 1996) a third (BRCA3) being actively sought. Breast families with mutations these appears as trait, affecting many half women each generation. Thus, both are considered high penetrance genes, majority individuals alterations will ultimately develop cancer. Mutations several other such p53 (associated Li-Fraumeni syndrome) MSH2 hereditary non-polyposis colon cancer) also causes cancer, but extremely rare general population. It very likely that contribute inherited where incidence elevated, appearance more scattered, because fewer numbers carriers result lower genes. These genetic complex what little known about candidates for low not yet clinical use.

参考文章(41)
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
Tucker Ma, Struewing Jp, Ponder Ba, Watson P, Lynch Ht, Easton Df, Prophylactic oophorectomy in inherited breast/ovarian cancer families. Journal of The National Cancer Institute Monographs. pp. 33- 35 ,(1995)
Narod S, Tonin P, Simard J, Morgan K, Lenoir G, Serova O, Durocher F, Lynch H, BRCA1 mutations in Ashkenazi Jewish women. American Journal of Human Genetics. ,vol. 57, pp. 189- 189 ,(1995)
Steven A. Narod, Gilbert M. Lenoir, David Goldgar, Patricia Tonin, Sylvie Mazoyer, Yin Y. Shugart, Henry T. Lynch, Nadine Puget, Olga M. Serova, Valérie Dubois, Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? American Journal of Human Genetics. ,vol. 60, pp. 486- 495 ,(1997)
J. Wagner-Costalas, D. C. Schultz, M. Daly, D. B. Berman, H. T. Lynch, A. K. Godwin, Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: A genetic study of 15 185delAG-mutation kindreds American Journal of Human Genetics. ,vol. 58, pp. 1166- 1176 ,(1996)
Virginia A. LiVolsi, Annmarie Cardonick, Beth Ann Rebane, John J. Mikuta, Ivor Benjamin, Kian Behbakht, Barbara L. Weber, Paul C. Liu, Jeff Boyd, Stephanie A. King, Mark A. Morgan, Masakuni Furusato, Mary Claire King, Fergus J. Couch, Patricia E. McGovern, Hiroyuki Takahashi, Andrew W. Menzin, Hsiu Chiang Chiu, Lori S. Friedman, Stephen C. Rubin, Mutation Analysis of the BRCA1 Gene in Ovarian Cancers Cancer Research. ,vol. 55, pp. 2998- 3002 ,(1995)
I Lerer, T Peretz, D Abeliovich, M Sagi, N Weinberg, G Amir, L Kaduri, J Zlotogora, N Heching, The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. American Journal of Human Genetics. ,vol. 60, pp. 505- 514 ,(1997)
Dominique Stoppa-Lyonnet, Fabienne Kerangueven, Brigitte Bressac-de-Paillerets, Tetsuro Noguchi, Jocelyne Jacquemier, Jean-Marc Guinebretiere, Hagay Sobol, François Eisinger, Daniel Birnbaum, Nicolas Janin, Jean-Philippe Peyrat, Truncation at Conserved Terminal Regions of BRCA1 Protein Is Associated with Highly Proliferating Hereditary Breast Cancers Cancer Research. ,vol. 56, pp. 3216- 3219 ,(1996)
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4